|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash and cash equivalents | ||||||||||
| Restricted cash | ||||||||||
| Investment securities | ||||||||||
| Accounts receivable, net of allowance of $4,130 at September 30, 2026 and $6,170 at December 31, 2025 | ||||||||||
| Income tax receivable | ||||||||||
| Prepaid expenses | ||||||||||
| Other current assets | ||||||||||
| Total current assets | ||||||||||
| Property, plant and equipment, net | ||||||||||
| Operating lease right-of-use assets, net | ||||||||||
| Intangible assets, net | ||||||||||
| Goodwill | ||||||||||
| Deferred costs | ||||||||||
| Other long-term assets | ||||||||||
| Total assets | ||||||||||
| Liabilities and stockholders’ equity | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | ||||||||||
| Accrued compensation | ||||||||||
| Aggregated funds payable | ||||||||||
| Other accrued expenses | ||||||||||
| Deferred revenue | ||||||||||
| Current portion of long-term debt | ||||||||||
| Nonrelated Party | ||||||||||
| Related Party | ||||||||||
| Total current portion of long-term debt | ||||||||||
| Current portion of operating lease liabilities | ||||||||||
| Current portion of finance lease liabilities | ||||||||||
| Total current liabilities | ||||||||||
| Long-term liabilities | ||||||||||
| Deferred tax liability | ||||||||||
| Long-term debt, net, less current portion | ||||||||||
| Nonrelated Party | ||||||||||
| Related Party | ||||||||||
| Total long-term debt, net, less current portion | ||||||||||
| Operating lease liabilities, net of current portion | ||||||||||
| Finance lease liabilities, net of current portion | ||||||||||
| Deferred revenue - long-term | ||||||||||
| Other long-term liabilities | ||||||||||
| Total liabilities | ||||||||||
| Stockholders’ equity | ||||||||||
| Preferred stock $0.01 par value - 100,000,000 and 100,000,000 shares authorized as of September 30, 2026 and December 31, 2025, respectively; zero shares issued or outstanding as of both September 30, 2026 and December 31, 2025 | ||||||||||
| Common stock $0.01 par value - 2,500,000,000 and 2,500,000,000 shares authorized at September 30, 2026 and December 31, 2025, respectively; 193,813,805 and 191,587,193 shares issued at September 30, 2026 and December 31, 2025, respectively; 192,265,522 and 191,587,193 shares outstanding at September 30, 2026 and December 31, 2025, respectively | ||||||||||
| Treasury stock, at cost | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||
| Retained earnings (accumulated deficit) | ||||||||||
| Total stockholders’ equity | ||||||||||
| Total liabilities and stockholders’ equity |
Loading...